
Reset all filters
01 1MSN LABORATORIES PRIVATE LIMITED Kardanur Village IN
02 1RAVI BIOLIFE PRIVATE LTD. Mumbai IN
03 1SHANDONG LIXIN PHARMACEUTICAL CO. LTD. Zibo CN
Reset all filters
01 3Nilotinib hydrochloride monohydrate
Reset all filters
01 1China
02 1India
03 1Blank
Reset all filters
01 3Valid
Nilotinib Hydrochloride Monohydrate
Certificate Number : R0-CEP 2020-176 - Rev 00
Status : Valid
Issue Date : 2022-12-06
Type : Chemical
Substance Number : 2993
Nilotinib Hydrochloride Monohydrate
Certificate Number : R0-CEP 2021-133 - Rev 00
Status : Valid
Issue Date : 2023-07-21
Type : Chemical
Substance Number : 2993
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Nilotinib Hydrochloride Monohydrate
Certificate Number : CEP 2022-425 - Rev 00
Status : Valid
Issue Date : 2024-04-19
Type : Chemical
Substance Number : 2993
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
53
PharmaCompass offers a list of Nilotinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nilotinib manufacturer or Nilotinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nilotinib manufacturer or Nilotinib supplier.
PharmaCompass also assists you with knowing the Nilotinib API Price utilized in the formulation of products. Nilotinib API Price is not always fixed or binding as the Nilotinib Price is obtained through a variety of data sources. The Nilotinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Nilotinib hydrochloride anhydrous manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nilotinib hydrochloride anhydrous, including repackagers and relabelers. The FDA regulates Nilotinib hydrochloride anhydrous manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nilotinib hydrochloride anhydrous API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nilotinib hydrochloride anhydrous manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nilotinib hydrochloride anhydrous supplier is an individual or a company that provides Nilotinib hydrochloride anhydrous active pharmaceutical ingredient (API) or Nilotinib hydrochloride anhydrous finished formulations upon request. The Nilotinib hydrochloride anhydrous suppliers may include Nilotinib hydrochloride anhydrous API manufacturers, exporters, distributors and traders.
click here to find a list of Nilotinib hydrochloride anhydrous suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Nilotinib hydrochloride anhydrous CEP of the European Pharmacopoeia monograph is often referred to as a Nilotinib hydrochloride anhydrous Certificate of Suitability (COS). The purpose of a Nilotinib hydrochloride anhydrous CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Nilotinib hydrochloride anhydrous EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Nilotinib hydrochloride anhydrous to their clients by showing that a Nilotinib hydrochloride anhydrous CEP has been issued for it. The manufacturer submits a Nilotinib hydrochloride anhydrous CEP (COS) as part of the market authorization procedure, and it takes on the role of a Nilotinib hydrochloride anhydrous CEP holder for the record. Additionally, the data presented in the Nilotinib hydrochloride anhydrous CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Nilotinib hydrochloride anhydrous DMF.
A Nilotinib hydrochloride anhydrous CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Nilotinib hydrochloride anhydrous CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Nilotinib hydrochloride anhydrous suppliers with CEP (COS) on PharmaCompass.
We have 2 companies offering Nilotinib hydrochloride anhydrous
Get in contact with the supplier of your choice: